文献速递神经肿瘤

预测高级别胶质瘤患者早期复发的列线图

A Nomogram for Predicting Early Recurrence in Patients with High-Grade Gliomas.
PubMed 文献 · World Neurosurg · 2022-05-16

该研究纳入154例高级别胶质瘤患者,依据病理诊断和神经肿瘤疗效评估标准分为复发组与未复发组,结合临床病理、基因及MRI参数构建预测早期复发的列线图。多因素分析显示肿瘤数目、瘤周水肿和IDH1为独立危险因素,列线图在阈值概率小于60%时净获益最高。

要点

  • 肿瘤数目、瘤周水肿和IDH1是高级别胶质瘤早期复发的独立危险因素。
  • 列线图在阈值概率小于60%时净获益最高,可辅助临床治疗决策。
  • IDH1的OR为4.200(95%CI 1.602, 10.013;P=0.004)。

核心结论

  • 列线图预测模型可有效辅助新诊断高级别胶质瘤患者的临床治疗决策。

研究设计与样本

  • 纳入154例高级别胶质瘤患者,依据病理诊断和神经肿瘤疗效评估标准分为复发组与未复发组,采用单因素和多因素logistic回归分析确定早期复发预测因素并构建列线图。

主要发现

  • 单因素分析显示肿瘤数目(OR 0.258,95%CI 0.104, 0.639;P=0.003)和瘤周水肿(OR 0.965,95%CI 0.942, 0.988;P=0.003;复发组均值22.04±17.21 mm,未复发组均值14.22±12.84 mm)与早期复发显著相关。
  • 与早期复发相关的遗传因素包括IDH1(OR 4.405,95%CI 1.874, 10.353;P=0.001)和O6-甲基鸟嘌呤-DNA甲基转移酶(OR 2.389,95%CI 1.234, 4.628;P=0.010)。
  • 多因素logistic回归分析显示肿瘤数目(OR 0.227,95%CI 0.084, 0.616;P=0.004)、瘤周水肿(OR 0.969,95%CI 0.945, 0.993;P=0.013)和IDH1(OR 4.200,95%CI 1.602, 10.013;P=0.004)为早期复发的独立危险因素。
  • 列线图在阈值概率小于60%时净获益最高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of the study was to develop a nomogram to predict early recurrence of high-grade glioma (HGG) based on clinical pathology, genetic factors, and magnetic resonance imaging parameters. METHODS: One hundred fifty-four patients with HGG were classified into recurrence and nonrecurrence groups based on the pathological diagnosis and Response Assessment in Neuro-Oncology criteria. Clinical pathology information included age, sex, preoperative Karnofsky performance status scores, grade, and cell proliferation index (Ki-67). Gene information included P53, isocitrate dehydrogenase 1 (IDH1), O6-methylguanine-DNA methyltransferase, and telomerase reverse transcriptase expression status. All patients underwent baseline magnetic resonance imaging before treatment, including T1-weighted imaging, T2-weighted imaging, contrast-enhanced T1WI, fluid attenuated inversion recovery, and diffusion-weighted imaging examinations. Tumor location, single/multiple tumors, tumor diameter, peritumoral edema, necrotic cyst, hemorrhage, average apparent diffusion coefficient value, and minimum apparent diffusion coefficient values were evaluated. Univariate and multivariate logistic regression analyses were used to determine the predictors of early recurrence and build a nomogram. RESULTS: Univariate analysis showed that the number of tumors (odds ratio [OR], 0.258; 95% confidence interval [CI]: 0.104, 0.639; P = 0.003) and peritumoral edema (OR, 0.965; 95% CI: 0.942, 0.988; P = 0.003; mean in the recurrence group = 22.04 ± 17.21 mm; mean in the nonrecurrence group = 14.22 ± 12.84 mm) were statistically significantly different in patients with early recurrence. Genetic factors associated with early recurrence included IDH1 (OR, 4.405; 95% CI: 1.874, 10.353; P = 0.001) and O6-methylguanine-DNA methyltransferase (OR, 2.389; 95% CI: 1.234, 4.628; P = 0.010). Multivariate logistic regression analysis revealed that the number of tumors (OR, 0.227; 95% CI: 0.084, 0.616; P = 0.004), peritumoral edema (OR, 0.969; 95% CI: 0.945, 0.993; P = 0.013), and IDH1 (OR, 4.200; 95% CI: 1.602, 10.013; P = 0.004) were independent risk factors for early recurrence. The nomogram showed the highest net benefit when the threshold probability was less than 60%. CONCLUSIONS: A nomogram prediction model can effectively aid in clinical treatment decisions for patients with newly diagnosed HGG.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Zhou Q, Ke X, Xue C, et al. A Nomogram for Predicting Early Recurrence in Patients with High-Grade Gliomas. World Neurosurg. 2022. PMID: 35589036. doi:10.1016/j.wneu.2022.05.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。